David T Hagerty Insider Trading $HSTO Histogen Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David T Hagerty.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David T Hagerty. David T Hagerty is Senior VP & CMO in Ardea Biosciences, Inc./DE ($IBPI) and EVP, Clinical Development in Conatus Pharmaceuticals Inc. ($CNAT).

David T Hagerty in Histogen Inc.

Trading Symbol: HSTO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David T Hagerty: EVP, Clinical Development
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 11 2019
$HSTO Market Capitalization: $127.38M
$HSTO Previous Close: $5.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of David T Hagerty in Histogen Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, IBPI, HSTO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 11 2019CNATConatus Pharmaceut ...Hagerty David TEVP, Clinical Devel ...Option ExerciseA2.00175,000350,000175,000
Feb 05 2018CNATConatus Pharmaceut ...Hagerty David TEVP, Clinical Devel ...Option ExerciseA5.1770,000361,90070,000
Feb 01 2017CNATConatus Pharmaceut ...Hagerty David TEVP, Clinical Devel ...Option ExerciseA4.21100,625423,631100,625
Feb 08 2016CNATConatus Pharmaceut ...Hagerty David TEVP, Clinical Devel ...Option ExerciseA1.8521,87540,46921,875
Feb 08 2016CNATConatus Pharmaceut ...Hagerty David TEVP, Clinical Devel ...Option ExerciseA1.85109,375202,344109,375

Page:   1